Most Popular
-
1
Torrential rainfall forces 1,500 to evacuate, causes widespread damage to homes, roads
-
2
[KH Explains] Can smart chargers ease tensions over EV fires?
-
3
1 in 5 households to have breadwinner over 80 in 30 years
-
4
[Online Predators] Online reviews of sex tourism in Southeast Asia proliferate
-
5
Middle East’s big AI push lures Korean tech firms
-
6
[Herald Review] 'Culinary Class Wars': fresh, creative survival show minus the drama
-
7
Arrival of fall calls for more outdoor festivals
-
8
New Fifty Fifty off to strong start
-
9
Assembly to review disputed appointment of national soccer team coach
-
10
Pikki Pikki dance: Korean cheerleader dance routine takes social media by storm
-
Samsung BioLogics scores certification from US FDA, EMA
Samsung BioLogics, a contract manufacturer of biologic drugs under South Korean electronics giant Samsung Group, said Wednesday that it has obtained six manufacturing certifications for biologic drugs produced at its first plant in Songdo, Incheon. Three monoclonal antibody drugs manufactured by Samsung BioLogics on behalf of its two clients Roche and Bristol-Myers Squibb were approved by the European Medicines Agency in July, the Korean biopharma CMO said. Of the three products, two were newly
TechnologySept. 7, 2016
-
Convenience stores tapping into overseas market with PB products
Amid a stagnant domestic economy, Korea’s convenience store chains are tapping into markets abroad to sell private brand products, industry sources said Tuesday.Major convenience store chain CU is exporting its self-branded cheese-flavored and red pepper-flavored instant noodles to Jumei, a Chinese online retailer.GS25, meanwhile, has been selling its own Chinese-style instant noodle product Gonghwachun in Australia and New Zealand. The product was made in partnership with a Chinese cuisine fran
IndustrySept. 7, 2016